1979
DOI: 10.1016/0002-9378(79)90717-8
|View full text |Cite
|
Sign up to set email alerts
|

New long-acting injectable microcapsule contraceptive system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

1
21
0
1

Year Published

1983
1983
2012
2012

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 96 publications
(23 citation statements)
references
References 8 publications
1
21
0
1
Order By: Relevance
“…Microspheres containing Norgestrel (MCN) were prepared by the solvent-evaporation process introduced by N.R Beck et al 3 with some modifications.…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Microspheres containing Norgestrel (MCN) were prepared by the solvent-evaporation process introduced by N.R Beck et al 3 with some modifications.…”
Section: Methodsmentioning
confidence: 99%
“…One of the potential applications is medical uses is to build sustained drug delivery system on which many developments have been made. Jackaniz, 1 Yolies,2 and Beck et al 3 ) studied the so called long-acting contraceptive devices using polylactides (PLA) as carrier. Polin 4 used copolymers of aminoacid as carrier.…”
mentioning
confidence: 99%
“…A peptide administered by a controlled delivery system that would lead to a constant release over a prolonged period of time could provide a continuous biological effect. Recently, a polymer of poly(DL-lactide-co-glycolide) (PLG) has been used to formulate microcapsules with steroids for long-acting contraceptive delivery systems (22)(23)(24) (26).…”
mentioning
confidence: 99%
“…In the following research, they developed a new sustained-release, injectable contraceptive which provides continuous controlled release of the steroid norethisterone, and the main drug can be slowly released from the microcapsules following intramuscular injection at a rate of 0.90 microgram/day from the polymer matrix. The results indicated ovulation functions was inhibited for 6 months and each one resumed normal ovulation within 1-2 weeks after the norethisterone blood level fell below the limit of detection 37 . However, tests showed burst effects were still remained in vivo release and the researches in the following years were still focused on hormone drugs.…”
Section: Microcapsulementioning
confidence: 93%